《中国糖尿病防治指南(2024版)》解读

尹经霞; 余丽; 蒲丹岚; 徐晓丽; 廖涌

doi:10.13406/j.cnki.cyxb.003749

重庆医科大学学报 ›› 2025, Vol. 50 ›› Issue (05) : 557 -564. DOI: 10.13406/j.cnki.cyxb.003749

内分泌调控与代谢疾病

《中国糖尿病防治指南(2024版)》解读

尹经霞 ¹ ,
余丽 ¹ ,
蒲丹岚 ² ,
徐晓丽 ¹ ,
廖涌 ¹

作者信息 +

Interpretation of the China Guidelines for the Prevention and Treatment of Diabetes （2024 Edition）

Jingxia Yin ¹ ,
Li Yu ¹ ,
Danlan Pu ² ,
Xiaoli Xu ¹ ,
Yong Liao ¹

Author information +

文章历史 +

PDF (697K)

摘要

近年来,国内外关于糖尿病的研究进展明显,不断涌现出新的诊疗技术和方法,临床研究证据不断积累和更新。为了能及时传递这些重要进展,中华医学会糖尿病学分会积极组织专家对中国糖尿病防治指南进行了更新,旨在为糖尿病的防治工作提供更全面、更科学的指导,促进临床医师对糖尿病规范化综合管理,让糖尿病患者得到标准化、个体化的治疗方案,提高治疗效果和生活质量。

Abstract

In recent years，significant progress has been made in diabetes research both domestically and internationally，new diagnosis and treatment techniques and methods have been constantly emerging，and clinical research evidence has been continuously accumulated and updated. To keep pace with these important developments，the Diabetes Branch of the Chinese Medical Association has actively organized experts to update the China Guidelines for the Prevention and Treatment of Diabetes. This update aims to provide a more comprehensive and scientific guide for diabetes prevention and treatment，greatly promote the standardized and integrated management of diabetes by clinicians，and ensure that patients receive standardized and personalized treatment plans to improve therapeutic outcomes and quality of life.